Transmitochondrial mice as models for mitochondrial DNA-based diseases

Kazuto Nakada1, Jun-Ichi Hayashi

  • 1Graduate School of Life and Environmental Sciences, University of Tsukuba, Tsukuba, Ibaraki 305-8572, Japan.

Experimental Animals
|November 2, 2011
PubMed

Insights

Researchers created "mito-mice" with mutated mitochondrial DNA (mtDNA) to study mtDNA diseases. These mice exhibit various symptoms, aiding in understanding and treating mitochondrial disorders.

Area of Science:

  • Genetics and Molecular Biology
  • Cell Biology
  • Pathology

Background:

  • Mitochondrial genome (mtDNA) mutations are linked to numerous diseases including neurodegeneration, diabetes, cancer, and aging.
  • Understanding the pathophysiology of mtDNA-based disorders requires robust animal models.

Purpose of the Study:

  • To generate and characterize novel mouse models (mito-mice) carrying pathogenic mtDNA mutations.
  • To investigate the phenotypic consequences of specific mtDNA mutations in vivo.

Main Methods:

  • Mitochondria with pathogenic mtDNA mutations were introduced into mouse zygotes and embryonic stem (ES) cells.
  • Three types of mito-mice were generated, including those with heteroplasmic wild-type and deleted mtDNA (ΔmtDNA).

Main Results:

  • Mito-mice with a high load of deleted mtDNA (mito-miceΔ) displayed mitochondrial respiration defects.
  • These defects resulted in a spectrum of mitochondrial disease phenotypes, including lactic acidosis, myopathy, heart block, infertility, and renal failure.
  • Mito-miceΔ exhibited symptoms such as low body weight, ischemia, deafness, and long-term memory deficits.

Conclusions:

  • The generated mito-mice serve as valuable models for studying mtDNA-based diseases.
  • These models facilitate the investigation of disease mechanisms and the evaluation of potential therapeutic strategies for mitochondrial disorders.